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A Rochalimaea-like organism (strain F9251) was isolated from a patient with endocarditis after blood drawn
for culture before antimicrobial therapy was subcultured onto blood and chocolate agars and incubated for 2
weeks in 5% CO2. The strain was phenotypically similar to known Rochalimaea species. The cellular fatty acid
composition of strain F9251 was close to but distinct from those of the three known Rochalimaea species and
was most similar to that of R. vinsonii. Labeled DNA from strain F9251 was 59 to 67% related to DNAs from
type strains of the three described Rochalimaea species, and its 16S rRNA gene sequence was 98.9%o or more
homologous to their 16S rRNA gene sequences. These findings support classification of F9251 as a new
Rochalimaea species, for which the name Rochalimaea elizabethae sp. nov. is proposed. The patient infected
with the organism had large bacterial vegetations on his aortic valve and was cured with antibiotics and
valve-replacement surgery. Recognition of the procedures required to identify this and other Rochalimaea
species suggests that clinical laboratories should prolong the incubation times of cultures of blood and tissue
from patients with suspected endocarditis, patients with fever of unknown origin, and immunocompromised
patients with fever so that the full spectrum of disease caused by these organisms can be recognized.
Three Rochalimaea species (family Rickettsiaceae) have
been described. R. quintana, the type species and causative
agent of trench fever, was originally termed "Rickettsia
quintana" by Schmincke in 1917 (35), but the organism was
transferred to the genus Rochalimaea by Krieg (20) in 1961.
The second species, originally referred to as the Canadian
vole agent (2), was formally described in 1982 and was
named R. vinsonii (50). R vinsonii has been isolated only
once, from voles on Grosse Isle, Quebec, Canada (2, 51).
The third Rochalimaea species, R. henselae (28, 52), was
first isolated by Slater, Welch, and coworkers (37, 52) and
was first detected by Relman and colleagues (32) in tissue
samples from patients with bacillary angiomatosis. This
organism has been isolated from the blood of patients
infected with the human immunodeficiency virus (HIV),
transplant recipients, immunocompetent patients with bac-
teremia, and a patient with peliosis hepatis (52). Relman et
al. (33) demonstrated that the rRNA sequences of isolates
detected in the blood and organisms detected in the tissues
of patients with bacillary angiomatosis represented the same
species. By direct cultivation of cutaneous and osseous
biopsy specimens with eukaryotic tissue culture endothelial
cells, Koehler and coworkers (18) have isolated R. henselae
from one patient and R. quintana from three patients with
bacillary angiomatosis, suggesting an etiologic role for both
species. Organisms were also recovered from the blood of
these patients, but no cases of endocarditis caused by
Rochalimaea species have been reported.
In 1986, we isolated an unidentifiable, fastidious organism
from a patient with endocarditis. The organism was reexam-
* Corresponding author.
ined in 1992 after the microbiological and molecular charac-
teristics of R. henselae were reported (28, 52) and was found
to be a fourth species of Rochalimaea. We describe the
patient with endocarditis from whom this organism was
isolated and propose designation of the bacillus as a new
species, Rochalimaea elizabethae sp. nov.
MATERIALS AND METHODS
Strains. R. quintana type strain ATCC VR-358 and R.
vinsonii type strain ATCC VR-152, which were obtained
from the American Type Culture Collection, were provided
by Ted Tzianabos, Viral and Rickettsial Zoonoses Branch,
Division of Viral and Rickettsial Diseases, National Center
for Infectious Diseases, Centers for Disease Control and
Prevention (CDC). R. henselae type strain ATCC 49882
(Houston 1) was sent to CDC for identification by the
Veterans Administration Hospital in Houston, Tex., and
was obtained from R. L. Regnery, Viral and Rickettsial
Zoonoses Branch, CDC. R. henselae 87-66, 88-712, 89-674,
and 90-615 were obtained from David F. Welch, University
of Oklahoma Health Sciences Center, Oklahoma City, and
have been described previously (52). The type strain of
Bartonella bacillifor,nis, ATCC 35685, has also been de-
scribed (7). Strain F9251 (=B-91-002005 = ATCC 49927) was
sent to CDC by the Massachusetts State Laboratory Insti-
tute, which received it from Saint Elizabeth's Hospital in
Brighton, Mass.
Primary isolation. Blood obtained from the patient before
the start of antimicrobial therapy was inoculated into BAC-
TEC 460 blood culture medium (Johnson Laboratories,
Towson, Md.). One bottle was vented for recovery of
aerobes, and one was kept closed to allow anaerobic growth.
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The bottles were incubated at 35°C for 3 weeks and were
then stored at room temperature. When the cultures had not
yielded any visible growth at 1 week, subcultures (0.1 ml)
from an aerobic bottle were made to tryptic soy agar (TSA)
supplemented with 5% sheep blood (sheep blood-TSA; BBL
Microbiology Systems, Cockeysville, Md.) and chocolate
agar (BBL), as well as to sheep blood-TSA streaked with
Staphylococcus aureus. Incubation was done at 35°C in 5%
CO2.
After 3 weeks, samples from both the aerobic and anaer-
obic bottles were subcultured on chocolate agar, sheep
blood-TSA, Campy BAP plate (BBL), Thayer-Martin plate
(BBL), and brain heart infusion agar with 5% sheep blood
(BBL). The plates were incubated at 35°C in air, in 5 to 10%
CO2 (Campy pouch bags; BBL), anaerobically (GasPak
pouch; BBL), and at 42°C in 5 to 10% CO2. Once isolated,
Rochalimaea-like strain F9251 was cultivated on chocolate
agar for phenotypic tests. The organism was stored at -70°C
in semisolid heart infusion agar (HIA) or in defibrinated
whole rabbit blood.
Samples of blood drawn after the antimicrobial therapy
was begun were inoculated into BAClEC 660-NR 6A, 7A,
and 16B (resin) bottles (Becton Dickinson and Co., Paramus,
N.J.) and were processed with the BACTEC 660-NR sys-
tem. At the time of the patient's valve-replacement surgery,
tissue from his aortic valve was ground and inoculated onto
standard media, including thioglycolate and chopped meat
broth. The cultures were maintained for 21 days.
Biochemical tests. For the initial biochemical tests we used
standard methods (21). Preformed enzymes were tested by
using the RapID ANA II system according to the manufac-
turer's directions (Innovative Diagnostic Systems, Inc., At-
lanta, Ga.). Gram staining and biochemical tests were done
as described previously (10). The strains were stored in
defibrinated rabbit blood in a vapor-phase liquid nitrogen
freezer. Inocula for biochemical evaluations were obtained
by growing strains on HIA supplemented with 5% rabbit
blood (rabbit blood-HIA; BBL) or on chocolate agar for 2 to
3 days at 35°C in candle extinction jars. Cells suspended in
heart infusion broth were observed for motility with an oil
immersion (x 1,000) objective.
Antibiotic susceptibility. Antibiotic susceptibility was de-
termined by use of the disk method of Bauer and associates
(3). Colonies from a chocolate agar plate incubated for 96 h
were suspended in Mueller-Hinton broth (BBL) and were
used to inoculate a chocolate agar plate (BBL). Standard
antibiotic-containing disks (BBL) were dropped on the
plates, which were incubated for 5 days in 5% CO2. The
clear zone around each disk was measured to the nearest
millimeter.
Cellular fatty acids (CFAs). Cells for fatty acid analysis
were grown on rabbit blood-HIA at 35°C for 2 to 5 days. The
cells were saponified, and the liberated fatty acids were
methylated and analyzed by capillary gas-liquid chromatog-
raphy (23). Identification of fatty acids and determination of
the locations of double bond positions in monounsaturated
acids were accomplished by gas-liquid chromatography and
gas-liquid chromatography-mass spectrometry (23).
DNA methods. To obtain cells for DNA extraction, strains
were grown on rabbit blood-HIA at 35°C for 3 to 4 days. The
DNA extraction and purification procedures and the hy-
droxyapatite hybridization method have been described pre-
viously (6). Divergence in related sequences was estimated
to be approximately 1% for each degree of decreased ther-
mal stability in a heterologous reassociated DNA duplex
compared with that in the homologous reassociated DNA
duplex (6). Divergence was calculated to the nearest 0.5%.
DNA was labeled enzymatically in vitro with [a-32P]dCTP
by use of a nick translation reagent kit (GIBCO BRL,
Gaithersburg, Md.). The guanine-plus-cytosine (GC) content
of DNA was determined spectrophotometrically by the
method of Marmur and Doty (22). The values obtained were
normalized to a Proteus mirabilis control strain with a GC
content of 40 mol%.
PCR amplification of rDNA. Template DNA for direct
sequencing was produced by enzymatic amplification of 16S
rDNA by using the primers fDl and rDl described by
Weisburg and coworkers (48). The restriction enzyme linker
region present in the original oligonucleotides was omitted,
resulting in a primary structure for fDl of 5'-AGAG'17''l
GATCCTGGCTCAG-3' and a primary structure for rDl of
5'-AAGGAGGTGATCCAGCC-3'. In addition, primer rDl
was labeled at the 5' end with biotin during oligonucleotide
synthesis with biotinylated phosphoramidites (Cambridge
Research Biochemicals, Wilmington, Del.). Approximately
10 ng of bacterial genomic DNA was amplified in a 100-,ul
reaction containing 10 pmol of each primer, 200 ,umol each of
dATP, dCTP, dGTP, and dTTP (Pharmacia LKB Biotech-
nology Inc., Piscataway, N.J.), and 2.5 U of AmpliTaq DNA
polymerase (U.S. Biochemical, Cleveland, Ohio) in lx
GeneAmp polymerase chain reaction (PCR) buffer (Perkin-
Elmer Corp., Norwalk, Conn.). Amplification was carried
out in a Perkin-Elmer DNA thermal cycler under the follow-
ing conditions: an initial 3-min DNA denaturation at 94°C
was followed by 25 cycles consisting of 1 min at 94°C, 1 min
at 45°C, and 1.5 min at 72°C. During the last cycle, the
incubation at 72°C was increased to 5 min to allow for
complete extension of PCR products.
PCR products were purified by using Dynabead M-280
streptavidin-coated magnetic beads (Dynal Inc., Great
Neck, N.Y.) and a modification of the method of Hultman
and associates (16). The beads were washed three times in
saline buffer (1 M NaCl, 20 mM Tris-HCl [pH 7.5], 1 mM
EDTA) and were resuspended in this buffer at their original
concentration of 10 mg/ml. A pool of five amplification
reactions was added to 200 ,l of beads, and the mixture was
incubated at ambient temperature, with mixing, for 15 min.
A neodymium-iron-boron permanent magnet was used to
sequester the beads and bound DNA, the supernatant was
discarded, and the beads were washed once with 250 ,ul of
TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA). The
bound DNA was denatured by adding 50 ,ul of 0.1 M NaOH.
After 15 min of incubation, the supematant containing the
eluted DNA strand was removed, neutralized with 5 RI of 1
M HCl, and buffered to pH 7.5 by adding 5 pl of 1 M
Tris-HCl; the total volume was adjusted to 75 ,ul with H20.
The DNA strand left bound to the beads was washed once
with 250 pl of NaOH and three times with TE and was
suspended in 75 ,ul of water.
Sequencing method and data analyses. Seven microliters of
bead suspension (possessing the DNA strand complemen-
tary to the 16S rRNA) or eluted DNA strand solution was
used for each sequencing reaction. Reactions were accom-
plished with T7 DNA polymerase (Sequenase 2.0; U.S.
Biochemical), incorporating [a-35S]dATP as the label. The
set of 10 oligonucleotides used as sequencing primers for the
eluted strand has been described previously (39). Reverse
complementary oligonucleotides to the 10 oligonucleotides
were used to sequence the bound strand. Sequencing reac-
tions were resolved on 8% polyacrylamide gels containing 7
M urea (Marathon Gel-Mix 8; GIBCO BRL). After electro-
phoresis, the gels were transferred directly to paper and
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dried under vacuum. Autoradiographs were allowed to ex-
pose for 2 to 7 days.
The 16S rRNA sequences of 16 species of the order
Rickettsiales and Anacystis nidulans were aligned by using
the multisequence alignment program PILEUP, which is
part of the GCG software package (12). Previously published
sequences (1, 26, 28, 39, 40, 48, 49) were obtained from the
GenBank data base. The sequence alignment was edited to
remove regions of alignment uncertainty, leaving 1,263 po-
sitions for calculation of evolutionary distance. Phylogenetic
relationships were inferred with version 3.4 of the PHYLIP
software package (15). A similarity matrix was calculated by
the method described by Jukes and Cantor (17). The den-
drogram was constructed by using the neighbor-joining
method of Saitou and Nei (34).
Nucleotide sequence accession numbers. The sequence for
R. elizabethae F9251 has been deposited in the GenBank,
EMBL, and DDBJ data bases under accession number
L01260. The sequence for R. vinsonii was submitted to the
same data bases under accession number L01259.
RESULTS
Case report. A 31-year-old man presented with a 2-month
history of fatigue, malaise, anorexia, and shortness of breath
accompanied by a weight loss of 9 kg. He had sustained
lacerations on the third and fourth fingers of his left hand 2
weeks before the onset of these symptoms. There was no
history of intravenous drug use, exposure to pets or other
animals, recent dental work, or significant medical condi-
tions. In the patient's medical record, there was no mention
of the circumstances leading to the lacerations. He was born
in Puerto Rico.
On initial evaluation, the patient had an oral temperature
of 39°C, a blood pressure of 105/40 mm Hg, multiple infected
teeth, a 4/6 diastolic murmur of aortic regurgitation, an S3
cardiac gallop, and a splinter hemorrhage in the left index
finger. A two-dimensional echocardiogram revealed large
vegetations on the aortic valve and severe aortic regurgita-
tion. A serum test for HIV antibody yielded negative results.
The patient became afebrile after 48 h of therapy with
intravenous nafcillin and gentamicin, and he remained with-
out fever throughout his hospitalization. A stool examination
showed larvae of Strongyloides stercoralis, and the patient
was treated with thiabendazole for 2 days. He developed
increasing congestive heart failure, and a decision was made
to replace his aortic valve surgically.
On the 16th hospital day, seven infected teeth were
removed. On the 17th hospital day, because of concern
about a prolonged bleeding time of greater than 15 min and
the patient's imminent surgery, the antibiotic regimen was
changed to vancomycin and imipenem. On the next day, the
patient underwent aortic valve replacement. During the
operation, he was found to have a tricuspid aortic valve with
vegetations on all three cuspids (Fig. 1). Gram staining of the
aortic tissue vegetation appeared to show abundant minute
coccobacillary organisms.
The patient recovered from surgery and was discharged on
the 24th postoperative day, after 6 weeks of intravenous
antibiotic therapy. He was treated as an outpatient with oral
trimethoprim-sulfamethoxazole for 5 additional weeks.
There was no evidence of relapse or recurrence of endocar-
ditis for the subsequent 2.5 years, after which he was lost to
follow-up.
Primary isolation. Cultures of blood samples drawn before
the patient received antimicrobial therapy showed no visible
growth after 3 weeks of incubation. Subculture of a sample
from the aerobic bottle done approximately 1 week after
inoculation grew small, dry colonies that were adherent to
the agar and that were noticed after 14 days of incubation on
blood and chocolate agars at 35°C in 5 to 10% CO2. Repeat
subculture from both the aerobic and anaerobic bottles
yielded a faint growth of dry, rough colonies after 10 days,
confirming the original isolation of strain F9251, which was
subsequently recognized as a Rochalimaea-like organism.
Cultures of blood obtained 2 days after the start of therapy
with nafcillin and gentamicin were negative. Cultures of the
tissue from the aortic valve grew catalase-positive anaerobic
diphtheroids in broth medium after 2 weeks of incubation.
These organisms were thought to be contaminants and were
not further identified.
Strain F9251 grew best on chocolate or sheep blood-TSA
at 35°C in 5 to 10% CO2. It did not grow aerobically at 42°C,
anaerobically, in stationary broth media, on Campy BAP
plates, or on Thayer-Martin plates containing antibiotics.
After multiple passages, the growth rate increased and
colonies that were less adherent to the agar than the initial
isolate could be seen after 48 to 72 h of incubation.
Phenotypic characteristics. Gram staining revealed thin,
short, straight and slightly curved gram-negative bacilli (Fig.
2). Catalase, oxidase, and spot indole tests were negative.
On initial isolation, the organism could not be identified as a
known species. It was subsequently sent to the Massachu-
setts State Laboratory Institute and CDC. Neither of those
laboratories could identify the organism.
However, after a Rochalimaea species was isolated in a
patient with bacillary angiomatosis and bacteremia and the
phenotypic characteristics of R. henselae were described
(28, 37, 52), strain F9251 was recognized as being Rochali-
maea-like and was reexamined. In the RapID ANA II
system, Rochalimaea-like strain F9251 cleaved leucylgly-
cine, glycine, proline, phenylalanine, arginine, and serine,
yielding the code number 000671, which is identical to that
obtained for R. henselae (28).
The phenotypic characteristics of strain F9251 were com-
pared with those of known Rochalimaea species (Table 1).
There were few positive characteristics other than the hy-
drolysis of the same six substrates. The oxidase reaction,
when tested by the Kovacs procedure, was weakly positive
at 9 s for strains of R. quintana and R. vinsonii but was
negative for three strains ofR. henselae and for strain F9251.
Strain F9251, the type strains of R. quintana and R. vinsonii,
and one of three R. henselae strains grew within 72 h on HIA
around an X (hemin) strip. All the Rochalimaea strains grew
on HIA supplemented with rabbit blood. F9251 produced a
zone of incomplete clearing (not greening) on rabbit blood-
HIA after incubation for 3 to 4 days.
Antibiotic susceptibility. Strain F9251 was susceptible to
all antibiotics tested (erythromycin, ciprofloxacin, cefoxitin,
gentamicin, vancomycin, and oxacillin).
Cell wall fatty acids. The CFA compositions of each
Rochalimaea species and Rochalimaea-like strain F9251
were characterized by using large amounts of cis-11-octade-
canoate (C18:i17c), hexadecanoate (C16:0), and octade-
canoate (C18:0), which accounted for 64 to 97% of total acids
(Table 2). In addition, all contained C17:0 (1 to 21%) and trace
to small amounts of C16:1w7c, C17:1i,6c, C18:2, and C18:1.9c-
No hydroxy or cyclopropane acids were present.
GC content and DNA relatedness. Spectrophotometric
assessments showed that the GC content ofDNA from strain
F9251 was 41.0 mol%; those of the type strains of Rochali-
maea species were 40.3 mol% for R. quintana, 41.1 mol%
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FIG. 1. Hematoxylin-eosin-stained section of aortic valve showing fibrin vegetation with acute inflammation and necrosis of underlying
valve substance. Magnification, x 125.
for R. vinsonii, and 41.0 mol% for R henselae. Labeled
DNA from strain F9251 was 59 to 67% related to type strains
of the three described Rochalimaea species at 55°C, an
optimal DNA reassociation criterion (Table 3). The diver-
gence in related sequences was 12 to 13%, and the related-
ness under a stringent criterion for DNA reassociation was
approximately 15%. In reciprocal reactions with labeled
DNA fromR henselae, the relatedness was 49%, with 9.5%
divergence and 16% relatedness at 75°C.
16S rRNA sequence analysis. The partial 16S rRNA gene
sequence from strain F9251 is shown in Fig. 3 and is aligned
with sequences from other species of Rochalimaea and B.
bacilliformis. A total of 1,466 nucleotide positions, corre-
sponding to Escherichia coli sequence positions 23 to 1,496
(8), were determined. This represents approximately 95% of
the gene. An identical region of the 16S rRNA gene from R.
vinsonii was also sequenced. These data show good agree-
ment with a 16S gene sequence from the same strain of R.
vinsonii reported by Regnery et al. (28). In an overlapping
region of 1,415 nucleotides between these two sequences,
only a single discrepancy was noted, the occurrence of a
guanosine residue at position 875 in Fig. 3 which does not
appear in the previously published sequence. The 16S rRNA
sequence of B. bacilliformis type strain ATCC 35695 was
first determined, using reverse transcriptase, by O'Connor
and others (26) and was subsequently determined by Birtles
and colleagues (4) and Relman and coworkers (31). Because
of discrepancies between these reported sequences, a 1,471-
nucleotide 16S rDNA sequence from B. bacillifornis ATCC
35685 was again determined. The corrected sequence shown
in Fig. 3 has been submitted to GenBank, where it appears
under the original accession number (M65249).
A sequence similarity matrix based on 16S sequence data
from members of the family Rickettsiaceae is shown in Table
4. The sequence from strain F9251 was most similar (99.4%)
to the R. vinsonii sequence, 99.2% similar to theR henselae
sequence, and 98.9% similar to the R. quintana sequence.
Within the genus Rochalimaea an average similarity value of
99.3% was calculated. The sequence from B. bacilliformis
exhibited a high degree of similarity to the sequences from
the three Rochalimaea species and strain F9251, with an
average value of 98.5% (this value is higher than that
reported previously [26] because of corrections to the Bar-
tonella sequence and masking of the sequences to remove
ambiguous regions from the alignment). By grouping these
five sequences, an average similarity of 99.0% is obtained.
The phylogenetic ordering of these organisms is demon-
strated in the dendrogram shown in Fig. 4. Rochalimaea
species and B. bacilliformis form a tight cluster with a
common line of descent separate from the genera Rickettsia
and Ehrlichia.
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FIG. 2. Gram-stained smear of strain F9251 taken from a colony
grown on a chocolate agar incubated for 96 h at 35°C in 5% Co2.
Magnification, x 1,250.
DISCUSSION
Our patient initially presented with culture-negative endo-
carditis, an entity that is becoming increasingly rare as
laboratories develop better techniques for culturing fastidi-
ous organisms (41, 43). Because our patient's history, clini-
cal evaluation, and echocardiographic findings provided
compelling evidence of bacterial endocarditis, we used as-
sessment methods designed to enhance the detection of
fastidious organisms. Strain F9251 was isolated only when
an aliquot of broth containing the patient's blood was
subcultured onto chocolate agar plates and the plates were
kept for 14 days in an atmosphere of 5 to 10% CO2. Standard
clinical laboratory practice would have dictated holding the
subculture plates for only 48 to 72 h, an incubation period
which is usually adequate for recovery of organisms known
to cause endocarditis, such as of the Haemophilus-Actinoba-
cillus-Cardiobacterium-Eikenella-Kingella group (46). In
contrast, Rochalimaea species require 10 to 21 days to grow
after subculture from broth medium or after culture of blood
samples by the lysis-centrifugation method (37). Our expe-
rience in isolating F9251 and appreciation of the techniques
required to isolate the other Rochalimaea species from
blood or tissue specimens (28, 37, 52) indicate that changes
are necessary in the methods of blood culture processing in
TABLE 1. Phenotypic characteristics of Rochalimaea species
R. quintana R. vinsonii R
Characteristic' ATCC ATCC henselae" F9251
VR-358T VR 152T
Gram reaction - - - -
Oxidase, routine
Oxidase, Kovacs +w +w -
Growth on HIA with:
X factor + + 1/3 +
V factor -
Rabbit blood + + + +
Hemolysis - - - +C
Motility - - - -
Indole production, spot test - - - -
Ornithine decarboxylase - - - -
Urea, Christensen - - - -
Acid from carbohydrates - - - -
Hydrolysis of:
Leucylglycine + + + +
Glycine + + + +
Proline + + + +
Phenylalanine + + + +
Arginine + + + +
Serine + + + +
a +, positive reaction within 48 h; -, negative reaction after 7 days; T, type
strain; w, weak reaction; fraction, number of positive strains/number of
strains tested.
b Strains ATCC 49882T, 87-66, and 88-712.
c Zone of incomplete clearing at 3 to 4 days on rabbit blood.
d D-Glucose, lactose, maltose, D-mannitol, D-xylose, and sucrose tested
with a rapid sugar test (10).
patients with suspected endocarditis, patients with fever of
unknown origin, and immunocompromised patients with
fever (28), in order to allow recognition of the full spectrum
of diseases associated with Rochalimaea and related spe-
cies.
Organisms that are difficult to identify and that appear to
be Rochalimaea-like species should be tested for preformed
enzymes, and their CFA composition should be determined.
Since the reactions of all the Rochalimaea strains we tested
in the RapID ANA II system (profile number 000671) were
the same as those for the type strain of R. henselae (28), the
system may be useful for identification to the genus level,
although it does not differentiate between the species of
Rochalimaea. The only phenotypic characteristic that dis-
tinguished strain F9251 from the strains of the other species
was a delayed hemolytic reaction on rabbit blood agar. At
present, only DNA hybridization, 16S rRNA sequencing,
and PCR-restriction endonuclease fragment length polymor-
phism analysis of the citrate synthase gene (18, 28) can be
used to identify Rochalimaea isolates to the species level.
Presumably, a species-specific antiserum, such as that pro-
duced from R. henselae by Welch and coworkers (52), could
be prepared against strain F9251 for use in identifying other
strains. It may be possible to develop genus-specific Roch-
alimaea antiserum to aid in identification.
The presence and relative amounts of the fatty acids in
Rochalimaea species are unique for this genus and currently
represent the most practical and rapid way to differentiate
these organisms from other bacterial genera. Initially, CFA
data provided a strong indication that strain F9251 was in the
genus Rochalimaea and was possibly a new species. These
data showed that the CFA content of F9251 was typical of,
but not identical to, that of other Rochalimaea species. R.
henselae and R. quintana have virtually identical CFA
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TABLE 2. CFA composition of Rochalimaea species
Organism % Fatty acidse
(no. of strains tested) C15:0 C16:1,.7c C16:0 C17:lwft C17:1,6c C17:0 C18:2 C18:1i9c C18:1i7c C18:0
R. henselae (7) - Tr 17 - Tr 3 1 1 57 20
R. quintana (8) - Tr 18 - Tr 1 Tr Tr 59 21
R. vinsonii (1) 2 2 20 - 3 9 Tr Tr 54 9
Rochalimaea-like strain 2 1 13 1 8 21 1 1 43 8
F9251 (1)
a Numbers before the colons are the numbers of carbon atoms; numbers after the colons are the numbers of double bonds; o, double-bond position from the
hydrocarbon end of the carbon chain; c, cis isomer; values are the mean percentages of total fatty acids; Tr, 0.4 to 0.9%; -, not detected.
features and cannot be distinguished from each other by
fatty acid analysis. R vinsonii and strain F9251 had similar
CFA compositions, which differed from those ofR. quintana
andR henselae by the presence of C15:0, C17:1,,,c and larger
amounts of C17:0. However, strain F9251 contained more
C17:0 and less C16:0 and C18:1.7, than did R. vinsonii.
Although the differences in CFA composition remained
consistent upon repeated regrowth and retesting of each
species, they must be considered tentative until additional
strains are tested. The data in Table 2 are in general
agreement with those reported by Welch and associates (52),
except that the C13:1 acid observed by those investigators
was not present in any Rochalimaea strain that we tested.
There were other differences between our results and
those reported previously. Our results indicate that the GC
contents of strain F9251 and named Rochalimaea species
were between 40.3 and 41.1 mol%. These values were
greater than the level of approximately 39 mol% previously
observed for R. quintana and R vinsonii (42, 50). All GC
determinations made by us and others were done spectro-
photometrically by means of thermal denaturation analysis.
We used the equation of Marmur and Doty (22) whereas the
earlier evaluations used the equation of De Ley (11) to
determine the mol% GC from thermal denaturation. The
resulting difference in values was probably due to either
impurities in the DNA used or the calibration temperatures
of the spectrophotometer.
DNA-DNA hybridization remains the method of choice
for defining species (24, 47). The high level of DNA related-
ness ofRochalimaea-like strain F9251 to the three described
Rochalimaea species (49 to 67%; Table 3) leaves little doubt
that it represents a new species in the genus Rochalimaea.
The 16S rRNA sequence of F9251 is most homologous to the
16S rRNA sequences of the three existing Rochalimaea
species (98.9% or greater), supporting placement of this
strain in the genus Rochalimaea. The magnitudes of dissim-
ilarity between the F9251 sequence and the other three
Rochalimaea sequences are similar to those obtained by
comparing the sequences from the three Rochalimaea spe-
cies previously defined by DNA-DNA hybridization (52).
These findings, as well as the similarities observed in the
cultural, biochemical, and CFA characteristics, support the
classification of F9251 as a new species in the genus Roch-
alimaea. We propose the name Rochalimaea elizabethae sp.
nov. for this organism. The description of the new species is
given below.
The topology of the tree in Fig. 4 reveals that the genus
Rochalimaea is a monophyletic group which shares a com-
mon line of descent with B. bacillifonnis, a phylogenetic
relationship that has been noted previously (4, 26, 31). The
16S rRNA sequence reported by O'Connor et al. (26) was
91.7% homologous to that of R quintana. This level of
homology was well below that expected from the 32 to 47%
DNA relatedness between B. bacilliformis and Rochalimaea
species shown previously (52) and in the present study. We
therefore resequenced B. bacillifonnis 16S rRNA (Fig. 3),
obtaining 98.4% homology with R. quintana (Table 4). In
conjunction with the hybridization results, the genetic data
support the reclassification of the genus Rochalimaea into
the family Bartonellaceae and suggest the reordering of
these organisms into a single genus.
B. bacilliformis and Rochalimaea species are related both
genetically and by similarities in their associated clinical
presentations and transmission by vectors. As Welch and
colleagues (52) have observed, the histologic appearance of
bacillary angiomatosis (27); the chronic form of bartonello-
sis, verruga peruana; cat scratch disease; and Kaposi's
sarcoma show some similarities. Transmission by a vector
TABLE 3. DNA relatedness of Rochalimaea species
% Relatedness to labeled DNA from:
Source of unlabeled DNA Rochalimaea-like strain F9251 R henselae ATCC 49882T
55°C Da 70°C 55°C D 70"C
Rochalimaea-like strain F9251 100 0.0 100 49 9.5 16
R. henselae ATCC 49882T 67 12.5 16 100 0.0 100
R. henselae 89-674 100 1.0 100
R. henselae 90-615 99 0.5 98
R henselae 87-66 100 0.0 100
RI henselae 89-712 92 1.0 99
R. quintana ATCC VR-358T 59 13.0 15
R vinsonii ATCC VR-152T 66 12.0 16
B. bacillifoinns ATCC 35685T 32 17.0 47 16.5
aD, divergence within related sequences, calculated to the nearest 0.5%.
VOL. 31, 1993
 at UNIV O
F M
ASS M
ED SCH on July 15, 2008 
jcm.asm.org
D
ow
nloaded from
 
878 DALY ET AL. J. CLIN. MICROBIOL.
1l
RV TCCTG GCTCAGAACG AACGCTGGCG GCAGGCTTAA CACATGCAAG
RH CTCAGAACG AACGCTGGCG GCAGGCTTAA CACATGCAAG
RE TCCTG GCTCAGAACG AACGCTGGCG GCAGGCTTAA CACATGCAAG
BB TTTGATCCTG GCTCAGAACG AACGCTGGCG GCAGGCTTAA CACATGCAAG
RQ CTCAGAACG AACGCTGGCG GCAGGCTTAA CACATGCAAG
RV AATCTACCCA TCTCTACGGA ATAACACAGA GAAATTTGTG CTAATACCGT
TCGAGCGCAC TCTTTTAGAG
TCGAGCGCAC TCTTTTAGAG
TCGAGCGGCT CCTTTTGGAG
TCGAGCGCAC TCTTTTGCAG
TCGAGCGCAC TCTTTTAGAG
***A* **
ATACGTCCTT . AGGGAGAAA
RH AATCTACCCA TCTCTACGGA ATAACACAGA GAAATTTGTG CTAATACCGT ATACGTCCTT .AGGGAGAAA
RE AATCTACCCC TCTCTACGGA ATAACACAGA GAAATTTGTG CTAATACCGT ATACBTCCCT .TTGGAGAAA
BB AATCTACCCA TCTCTACGGA ATAACACAGA CAAATTTGTG CTAATACAGT ATACGTCCTT .CGGGAGAAA
RQ AATCTACCCA TCTCTACGGA ATAACACAGA GAAATTTGTG CTAATACCGT ATACGTCCCT CTGGGAGAAA
* * * **
RV GATTAGCTAG TTGGTGAGGT AACGGCTCAC CAAGGCGACG ATCCATAGCT GGTCTGAGAG GATGATCAGC
RH GATTAGCTAG TTGGTGAGGT AACGGCTCAC CAAGGCGACG ATCCATAGCT GGTCTGAGAG GATGATCAGC
RE GATTAGCTAG TTGGTGAGGT AACGGCTCAC CAAGGCGACG ATCCATAGCT GGTCTGAGAG GATGATCAGC
BB GATTAGCTAG TTGGTGAGGT AACGGCCCAC CAAGGCGACG ATCCATAGCT GGTCTGAGAG GATGATCAGC
RQ GATTAGCTAG TTGGTGAGGT AAGGGCTCAC CAAGGCGACG ATCCATAGCT GGTCTGAGAG GATGATCAGC
* *
RV CTACGGGAGG CAGCAGTGGG GAATATTGGA CAATGGGGGC AACCCTGATC CAGCCATGCC GCGTGAGTGA
RH CTACGGGAGG CAGCAGTGGG GAATATTGGA CAATGGGGGC AACCCTGATC CAGCCATGCC GCGTGAGTGA
RE CTACGGGAGG CAGCAGTGGG GAATATTGGA CAATGGGGGC AACCCTGATC CAGCCATGCC GCGTGAGTGA
BB CTACGGGAGG CAGCAGTGGG GAATATTGGA CAATGCGGGC AACCCTGATC CAGCCATGCC GCGTGAGTGA
RQ CTACGGGAGG CAGCAGTGGG GAATATTGGA CAATGCGGGC AACCCTGATC CAGCCATGCC GCGTGAGTGA
RV CCGGTGAAGA TAATGACGGT AACCGGAGAA GAAGCCCCGG CTAACTTCGT GCCAGCAGCC GCGGTAATAC
RH CCGGTGAAGA TAATGACGGT AACCGGAGAA GAAGCCCCGG CTAACTTCGT GCCAGCAGCC GCGGTAATAC
RE CCGGTGAAGA TAATGACGGT AACCGGAGAA GAAGCCCCGG CTAACTTCGT GCCAGCAGCC GCGGTAATAC
BB CCGGTGAAGA TAATGACGGT AGCCGGAGAA GAAGCCCCGG CTAACTTCGT GCCAGCAGCC GCGGTAATAC
RQ CCGGTGAAGA TAATGACGTT AACCGGAGAA GAAGCCCCGG CTAACTTCGT GCCAGCAGCC GCGGTAATAC
*
RV GGCGTAAAGC GCACGTAGGC GGATATTTAA GTCAGAGGTG AAATCCCAGG GCTCAACCCT GGAACTGCCT
RH GGCGTAAAGC (;CATGTAGGC GGATATTTAA GTCAGAGGTG AAATCCCAGG GCTCAACCCT GGAACTGCCT
RE GGCGTAAAGC GCACGTAGGC GGATATTTAA GTCAGAGGTG AAATCCCAGG GCTCAACCCT GGAACTGCCT
BB GGCGTAAAGC GCATGTAGGC GGATATTTAA GTCAGAGGTG AAATCCCAGG GCTCAACCTT GGAACTGCCT
RQ GGCGTAAAGC GCATGTAGGC GGATATTTAA GTCAGAGGTG AAATCCCAGG GCTCAACCCT GGAACTGCCT
* *
RV GTGAGTGGAA TTCCGAGTGT
RH GTGAGTGGAA TTCCGAGTGT
RE GTGAGTGGAA TTCCGAGTGT
BB GTGAGTGGAA TTCCGAGTGT
RQ GTGAGTGGAA TTCCGAGTGT
RV AAGCGTGGGG AGCAAACAGG
RH AAGCGTGGGG AGCAAACAGG
RE AAGCGTGGGG AGCAAACAGG
BB AAGCGTGGGG AGCAAACAGG
RQ AAGCGTGGGG AGCAAACAGG
RV CATTAAACAT TCCGCCTGGG
RH CGTTAAACAT TCCGCCTGGG
RE CATTAAACAT TCCGCCTGGG
BB CGTTAAACAT 'TCCGCCTGGG
RQ CGTTAAACAT TCCGCCTGGG
*
RV AACGCGCAGA ACCTTACCAG
RH AACGCGCAGA ACCTTACCAG
RE AACGCGCAGA ACCTTACCAG
BB AACGCGCAGA ACCTTACCAG
RQ AACGCGCAGA -CCTTACCAG
RV GTCAGCTCGT GTCGTGAGAT
RH GTCAGCTCGT GTCGTGAGAT
RE GTCAGCTCGT GTCGTGAGAT
BB GTCAGCTCGT GTCGTGAGAT
RQ GTCAGCTCG AGTGAGAT
RV TGATAAGCCG AGAGGAAGGT
RH TGATAAGCCG AGAGGAAGGT
RE TGATAAGCCG AGAGGAAGGT
O
TGAGCGGCAA ACGGGTGAGT AACGCGTGGG
TGAGCGGCAA ACGGGTGAGT AACGCGTGGG
CGAGCGGCAA ACGGGTGAGT AACGCGTGGG
TGAGCGGCAA ACGAGTGAGT AACGCGTGGG
TGAGCGGCAA ACGGGTGAGT AACGCGTGGG
* *
200v
GATTTATCGG AGATGGATGA GCCCGCGTTG
GATTTATCGG AGATGGATGA GCCCGCGTTG
GATTTATCGG AGATGGATGA GCCCGCGTTG
GATTTATCGG AGATGGATGA GCCCGCGTTG
GATTTATCGG AGGTGGATGA GCCCGCGTTG
300v
CACACTGGGA CTGAGACACG GCCCAGACTC
CACACTGGGA CTGAGACACG GCCCAGACTC
CACACTGGGA CTGAGACACG GCCCAGACTC
CACACTGGGA CTGAGACACG GCCCAGACTC
CACACTGGGA CTGAGACACG GCCCAGACTC
4007
TGAAGGCCCT AGGGTTGTAA AGCTCTTTCA
TGAAGGCCCT AGGGTTGTAA AGCTCTTTCA
TGAAGGCCCT AGGGTTGTAA AGCTCTTTCA
TGAAGGCCTT AGGGTTGTAA AGCTCTTTCA
TGAAGGCCCT AGGGTTGTAA AGCTCTTTCA
*
500,
GAAGGGGGCT
GAAGGGGGCT
GAAGGGGGCT
GAAGGGGGCT
GAAGGGGGCT
TTGATACTGG
TTGATACTGG
TTGATACTGG
TTGATACTGG
TTGATACTGG
AGAGGTAAAA TTCGTAGATA TTCGGAGGAA CACCAGTGGC GAAGGCGGCT CACTGGTCCA
AGAGGTAAAA
AGAGGTAAAA
AGAGGTAAAA
AGAGGTAAAA
ATTAGATACC
ATTAGATACC
ATTAGATACC
ATTAGATACC
ATTAGATACC
GAGTACGGTC
GAGTACGGTC
GAGTACGGTC
GAGTACGGTC
GAGTACGGTC
CCCTTGACAT
CCCTTGACAT
CCCTTGACAT
CCCTTGACAT
CCCTTGACAT
GTTGGGTTAA
GTTGGGTTAA
GTTGGGTTAA
GTTGGGTTAA
GTTGGGTTAA
GGGGATGACG
GGGGATGACG
GGGGATGACG
TTCGTAGATA TTCGGAGGAA CACCAGTGGC GAAGGCGGCT CACTGGTCCA
TTCGTAGATA TTCGGAGGAA CACCAGTGGC GAAGGCGGCT CACTGGTCCA
TTCGTAGATA TTCGGAGGAA CACCAGTGGC GAAGGCGGCT CACTGGTCCA
TTCGTAGATA TTCGGAGGAA CACCAGTGGC GAAGGCGGCT CACTGGTCCA
CTGGTAGTCC ACGCCGTAAA CGATGAATGT TAGCCGTCGG GCGGTTTACT
CTGGTAGTCC ACGCCGTAAA CGATGAATGT TAGCCGTCGG GCGGTTTACT
CTGGTAGTCC ACGCCGTAAA CGATGAATGT TAGCCGTCGG GCGGTTTACT
CTGGTAGTCC ACGCCGTAAA CGATGAATGT TAGCCGTCGG GCAGTTTACT
CTGGTAGTCC ACGCCGTAAA CGATGAATGT TAGCCGTCGG GTGGTTTACT
**
GCAAGATTAA AACTCAAAGG AATTGACGGG GGCCCGCACA AGCGGTGGAG
GCAAGATTAA AACTCAAAGG AATTGACGGG GGCCCGCACA AGCG.TGGAG
GCAAGATTAA AACTCAAAGG AATTGACGGG GGCCCGCACA AGCGGTGGAG
GCAAGATTAA AACTCAAAGG AATTGACGGG GGCCCGCACA AGCGGTGGAG
GCAAGATTAA AACTCAAAGG AATTGACGGG GGCCCGCACA AGCG.TGGAG
CCCGATCGCG GAAGGTGGAG ACACCCTCCT TCAGTTAGGC TGGATCGGAG
CCCGATCGCG GAAGGTGGAG ACACCCTCCT TCAGTTAGGC TGGATCGGAG
CCCGATCGCG GAGAGTGGAG ACACTCTCCT TCAGTTAGGC TGGATCGGAG
CCCGATCGCG GAGAGTGGAG ACACTTTCCT TCAGTTAGGC TGGATCGGAG
CCCGATCGCG GAAGGTGGAG ACACCCTCCT TCAGTTAGGC TGGATCGGTG
** ** *
GTCCCGCAAC GAGCGCAACC CTCGCCCTTA GTTGCCAGCA TTCAGTTGGG
GTCCCGCAAC GAGCGCAACC CTCGCCCTTA GTTGCCAGCA TTTGGTTGGG
GTCCCGCAAC GAGCGCAACC CTCGCCCTTA GTTGCCAGCA TTAAGTTGGG
GTCCCGCAAC GAGCGCAACC CTCGCCCTTA GTTGCCAGCA TTCAGTTGGG
GTCCCGCAAC GAGCGCAACC CTCGCCCTTA GTTGCCATCA TTAAGTTGGG
* **
TCAAGTCCTC ATGGCCCTTA CGGGCTGGGC TACACACGTG CTACAATGGT
TCAAGTCCTC ATGGCCCTTA CGGGCTGGGC TACACACGTG CTACAATGGT
TCAAGTCCTC ATGGCCCTTA CGGGCTGGGC TACACACGTG CTACAATGGT
AGCGTTGTTC GGATTTACTG
AGCGTTGTTC GGATTTACTG
AGCGTTGTTC GGATTTACTG
AGCGTTGTTC GGATTTACTG
AGCGTTGTTC GGATTTACTG
6007
GTATCTTGAG TATGGAAGAG
GTATCTTGAG TGTGGAAGAG
ATATCTTGAG TGTGGAAGAG
ATGTCTCGAG TATGGAAGAG
ATGTCTCGAG TGTGGAAGAG
* * *
7007
TTACTGACGC TGAGGTGCGA
TTACTGACGC TGAGGTGCGA
TTACTGACGC TGAGGTGCGA
TTACTGACGC TGAGGTGCGA
TTACTGACGC TGAGGTGCGA
800V
GCTCGGTGGC GCACGTAACG
GCTCGGTGGC GCACGTAACG
GCTCGGTGGC GCACGTAACG
GCTCGGTGGC GCACGTAACG
ACTCGGTGGC GCACGTAACG
*
9007
CATGTGGTTT AATTCGAAGC
CATGTGGTTT AATTCGAAGC
CATGTGGTTT AATTCGAAGC
CATGTGGTTT AATTCGAAGC
CATGTGGTTT AATTCGAAGC
10007
ACAGGTGCTG CATGGCTGTC
ACAGGTGCTG CATGGCTGTC
ACAGGTGCTG CATGGCTGTC
ACAGGTGCTG CATGGCTGTC
ACAGGTGCTG CATGGCTGTC
11007
CACTCTAAGG GGACTGCCGG
CACTCTAGGG GGACTGCCGG
CACTCTAAGG GGACTGCCGG
CACTCTAAGG GGACTGCCGG
CACTCTAGGG GGACTGCCGG
*
12007
GGTGACAGTG GGCAGCGAGA
GGTGACAGTG GGCAGCGAGA
GGTGACAGTG GGCAGCGAGA
BB TGATAAGCCG AGAGGAAGGT GGGGATGACG TCAAGTCCTC ATGGCCCTTA CGGGCTGGGC TACACACGTG CTACAATGGT GGTGACAGTG GGCAGCGAAA
RQ TGATAAGCCG AGAGGAAGGT GGGGATGACG TCAAGTCCTC ATGGCCCTTA CGGGCTGGGC TACACACGTG CTACAATGGT GGTGACAGTG GGCAGCGAGA
FIG. 3. Alignment of partial 16S rRNA gene sequences from R. vinsonii (RV), R. henselae (RH), R. elizabethae (RE), B. bacilliformis
(BB), and R. quintana (RQ). The sequence of the noncoding (RNA-like) strand is shown. Alignment gaps at positions 161 and 875 are
indicated by dots. The asterisks indicate the lack of consensus at positions where the nucleotide sequence was determined for all genes in the
alignment. The positions of alignment uncertainty, observed in an alignment of 16 sequences from members of the order Rickettsiales (data
not shown) that were omitted from the phylogenetic analysis, are indicated by a line above these positions.
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ROCHALIMAEA ELIZABETHAE SP. NOV. 879
RV CW-GAGGTC GAGCTAATCT
RH CCGCGAGGTC GAGCTAATCT
RE CCGCGAGGTC GAGCTAATCT
BB CCGCAAGGTC GAGCTAATCT
RQ CCGCGAGGTC GAGCTAATCT
*
RV GCCACGGTGA ATACGTTCCC
RH GCCACGGTGA ATACGTTCCC
RE GCCACGGTGA ATACGTTCCC
BB GCCACGGTGA ATACGTTCCC
RQ GCCACGGTGA ATACGTTCCC
CCAAAAGCCA TCTCAGTTCG
CCAAAAGCCA TCTCAGTTCG
CCAAAAGCCA TCTCAGTTCG
CCAAAAGCCA TCTCAGTTCG
CCAAAAGCCA TCTCAGTTCG
GGGCCTTGTA CACACCGCCC
GGGCCTTGTA CACACCGCCC
GGGCCTTGTA CACACCGCCC
GGGCCTTGTA CACACCGCCC
GGGCCTTGTA CACACCGCCC
1300v
GATTGCACTC TGCAACTCGA GTGCATGAAG TTGGAATCGC TAGTAATCGT GGATCAGCAT
GATTGCACTC TGCAACTCGA GTGCATGAAG TCGGAATCGC TAGTAATCGT GGATCAGCAT
GATTGCACTC TGCAACTCGA GTGCATGAAG TTGGAATCGC TAGTAATCGT GGATCAGCAT
GATTGCACTC TGCAACTCGA GTGCATGAAG TCGGAATCGC TAGTAATCGT GGATCAGCAT
GATTGCACTC TGCAACTCGA GTGCATGAAG TTGGAATCGC TAGTAATCGT GGATCAGCAT
*
1400v
GTCACACCAT GGGAGTTGGT TTTACCCGAA GGTGCTGTGC TAACCGCAAG GAGGCAGGCA
GTCACACCAT GGGAGTTGGT TTTACCCGAA GGTGCTGTGC TAACCGCAAG GGGGCAGGCA
GTCACACCAT GGGAGTTGGT TTTACCCGAA GGTGCTGTGC TAACCGCAAG GAGGCAGGCA
GTCACACCAT GGGAGTTGGT TTTACCCGAA GGTGCTGTGC TAACCGCAAG GAAGCAGGCA
GTCACACCAT GGGAGTTGGT TTTACCCGAA GGTGCTGTGC TAACCGCAAG GAGGCAGGCA
RV ACCACGGTAG ,;GTCAGCGAC TGGGGTGAAG TCGTAACAAG
RH ACCACGGTAG GGTCAGCGAC TGGGGTG
RE ACCACGGTAG GGTCAGCGAC TGGGGTGAAG TCGTAACAAG
BB ACCACGGTAG GGTCAGCGAC TGGGGTGAAG TCGTAACAAG
RQ ACCACGGTAG G7GTCAGCGAC TGGGGTG
1471v
GTAGCCGTAG GGAACCTGTG GCTGGATCAC CT
GTAGCCGTAG GGAACCTGTG GCTGGATCAC CT
GTAGCCGTAG GGAACCTGCG GCTGGATCAC CT
FIG. 3-Continued
has been suggested forR vinsonii, which was isolated from
the spleens of voles and then experimentally transmitted by
the ear mite (Trombicula microti) to a hamster by Baker (2).
B. bacilliformis and R. quintana are transmitted by vectors
to humans (25, 45). In Oroya fever, the acute form of
bartonellosis (an infection transmitted by the sandfly), or-
ganisms can be isolated from the blood of patients when
blood samples are subcultured to medium containing rabbit
blood and incubated at 28 to 30°C (19). R. quintana (trans-
mitted by the louse) has been easily isolated for as long as 1
month after the illness from the blood of patients with trench
fever and from one volunteer who was inoculated experi-
mentally by Varela and associates (44). Koehler and cowork-
ers (18) have reported exposure to possible vectors in two of
their patients with bacillary angiomatosis; one patient whose
samples grew R quintana owned a pet rat and the patient
whose samples grew R henselae owned cats. The serologi-
cal data reported by Regnery and colleagues (29) implicate
Rochalimaea species as a possible etiologic agent of cat
scratch disease (30), and R. henselae has been cultured from
lymph nodes in two patients (53) and from the blood of a
domestic cat (29). However, the etiology of cat scratch
disease remains controversial. The proposed etiologic agent
was first reported to be a bacterium (14) that subsequently
was named Afipia felis (5); it has been detected by PCR in a
lymph node of a patient with the disease (9) and produced a
serological response in another patient (13). On balance, the
present data indicate that R. henselae and possibly other
Rochalimaea species may cause most cases of cat scratch
disease, but a possible role for A. felis has not been ruled
out, nor has the possibility of dual infection.
Our patient represents the first reported case of infection
caused by R. elizabethae sp. nov. and the first case of
TABLE 4. 16S rRNA similarity matrixa
% Similarity
Organism R R? JR R1 B.
vinsonii henselae quintana elizabethae bacilliformis
R. vinsonii
R. henselae 99.6
R. quintana 99.1 99.4
R. elizabethae 99.4 99.2 98.9
B. bacillifonnis 98.5 98.6 98.6 98.4
a Numbers represent percent similarity corrected for multiple base changes
by the method of Jukes and Cantor (17).
endocarditis caused by a Rochalimaea species. We can only
speculate why this infection developed. The patient had no
known exposure to animals or insect vectors, was not
apparently immunosuppressed, and was HIV antibody neg-
ative, in contrast to most patients reported to have bacillary
angiomatosis or bacteremia caused by R henselae (37, 38,
52). He did not have any predisposition to endocarditis, such
as cardiac valvular abnormalities. A risk factor for bactere-
mia was his poor dentition and, possibly, intestinal strongy-
loidiasis, an infection known to be associated with a predis-
position to bacteremia resulting from organisms in the stools
of patients with overwhelming infestations (36). Until the
ecological niche ofR elizabethae is identified, it cannot be
determined whether our patient's parasitic infection caused
by S. stercoralis played a part in the acquisition of this
organism.
Rapid, direct identification ofRochalimaea-like organisms
in blood or tissue would facilitate appropriate treatment for
future cases because blood cultures are likely to remain
negative for weeks. Cure of endocarditis depends on the use
of appropriate bactericidal agents for a prolonged time
period, and antimicrobial therapy for culture-negative endo-
carditis generally has consisted of a combination of ampicil-
FIG. 4. Phylogenetic tree for members of the order Rickettsiales,
with A. nidulans as the outgroup. The tree was inferred from 16S
rRNA similarity data by the neighbor-joining method (34). The bar
represents a 5% difference in nucleotide sequence.
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880 DALY ET AL.
lin or vancomycin and gentamicin. When given intrave-
nously for 2 to 6 weeks, this regimen produces cure rates of
92% in patients who become afebrile (43). This therapy,
however, may not be ideal for patients with Rochalimaea
infections, even though the organisms appear to be suscep-
tible to most antibiotics. Our patient was cured with a
combination of medical and surgical therapy, and R. eliza-
bethae sp. nov. was not recovered from blood cultures
obtained after 2 days of treatment with nafcillin and genta-
micin therapy or from the cardiac valve removed after 18
days of therapy, despite the presence of organisms on
pathologic examination. This suggests that the R. elizabe-
thae sp. nov. was susceptible in vivo to either nafcillin or
gentamicin or both of these agents, but the ideal therapy is
not known.
As laboratories become aware of the growth characteris-
tics of Rochalimaea species and physicians better under-
stand the illnesses caused by these pathogens, it is likely that
more cases will be recognized. With an increase in the
frequency of detection, more in vitro information about
antimicrobial susceptibility and in vivo data about clinical
risk factors for infection will emerge to help clinicians
correctly diagnose and treat patients infected with these
organisms.
Description of R. elizabethae sp. nov. R. elizabethae (e.liz'
a.beth.e.a. N.L. fem. adj. elizabethae), named after Saint
Elizabeth's Hospital, Brighton, Mass., where the organism
was isolated. Biochemical reactions are given in Table 1. Its
closest phenotypic relative is R. henselae, from which it
appears to be differentiated by incomplete hemolysis on
rabbit blood agar. It is presumed to be pathogenic for
humans.
Description of the type strain. The type strain of R.
elizabethae is F9251 (=B91-002005 = ATCC 49927). It
shares all the characteristics of the species. The GC content
of DNA was 41.0 mol%. It was isolated from the blood of a
man with endocarditis.
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ADDENDUM IN PROOF
DNA from the paraffin-embedded tissue block of the
patient's heart valve was amplified using Rochalimaea ge-
nus-specific 16S RNA primers and was positive (personal
communication, B. Swaminathan, Centers for Disease Con-
trol).
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